Anticorps Monoclonal anti-ANGPTL4
ANGPTL4 Monoclonal Antibody for WB, IF/ICC, Indirect ELISA
Hôte / Isotype
Mouse / IgG2b
Réactivité testée
Humain, souris
Applications
WB, IF/ICC, Indirect ELISA
Conjugaison
Non conjugué
CloneNo.
1D2H6
N° de cat : 67577-1-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
67577-1-PBS cible ANGPTL4 dans les applications de WB, IF/ICC, Indirect ELISA et montre une réactivité avec des échantillons Humain, souris
| Réactivité | Humain, souris |
| Hôte / Isotype | Mouse / IgG2b |
| Clonalité | Monoclonal |
| Type | Anticorps |
| Immunogène | ANGPTL4 Protéine recombinante Ag30070 |
| Nom complet | angiopoietin-like 4 |
| Masse moléculaire calculée | 45 kDa |
| Poids moléculaire observé | 45-50 kDa |
| Numéro d’acquisition GenBank | BC023647 |
| Symbole du gène | ANGPTL4 |
| Identification du gène (NCBI) | 51129 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par protéine A |
| Tampon de stockage | PBS only |
| Conditions de stockage | Store at -80°C. 20ul contiennent 0,1% de BSA. |
Informations générales
Angiopoietin-like protein 4 (ANGPTL4), a member of the angiopoietin-like protein subfamily, is a secretory protein that functions as an important modulator of glucose and lipid metabolism. ANGPTL4 inhibits lipoprotein lipase (LPL)-dependent lipolysis thereby limiting the uptake of free fatty acids. Overexpression of ANGPTL4 results in hypertriglyceridemia, while ANGPTL4 deficiency suppresses foam formation in macrophages and protects against atherosclerosis. ANGPTL4 may play a role in several cancers and it also has been shown to prevent the metastatic process by inhibiting vascular activity as well as tumor cell motility and invasiveness. Decreased expression of this protein has been associated with type 2 diabetes. ANGPTL4 has three isoforms, 45 kDa, 41 kDa and 27 kDa.















